Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Review Article
Commentary on Bevacizumab in Ovarian Cancer: Focus on Clinical Data andFuture Perspectives
Vanda Salutari*, Giovanni Scambia
Gynecology Oncology Unit, Policlinico Universitario Agostino Gemelli, Rome, Italy
- *Corresponding Author:
- Vanda Salutar
Gynecology Oncology Unit
Policlinico Universitario Agostino Gemelli
Rome, Italy
Tel: +39 06 3551 0330
E-mail: Vanda.Salutari@libero.it
Received Date: January 30, 2016; Accepted Date: February 19, 2016; Published Date: February 26, 2016
Citation: Salutari V, Scambia G (2016) Commentary on Bevacizumab in Ovarian Cancer: Focus on Clinical Data and Future Perspectives. Trends Gynecol Oncol 1:103. doi:10.4172/CTGO.1000103
Copyright: © 2016 Salutari V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
